Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page. This reflects a minor revision history update without altering the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor platform update to the study page. This change reflects backend/content refresh rather than any new information about the trial itself.
    Difference
    0.0%
    Check dated 2026-07-03T22:55:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added to the page and the previous v3.6.0 entry was removed, updating the study record's version history. This reflects an updated page version without altering study data or content.
    Difference
    0.0%
    Check dated 2026-06-26T23:15:18.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added recruitment status indicating that the study is no longer recruiting participants. New help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were introduced, and the revision/versioning was updated to v3.6.0 while the older heading and revision note were removed.
    Difference
    0.3%
    Check dated 2026-06-12T16:14:59.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page shows an updated revision tag (v3.5.5) replacing the previous v3.5.4, indicating a new version of the page's metadata.
    Difference
    0.0%
    Check dated 2026-06-05T12:19:00.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.5.3 to Revision: v3.5.4, representing a newer page version. This update pertains to metadata/formatting rather than substantive study details.
    Difference
    0.0%
    Check dated 2026-05-15T05:47:50.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.